WO2002103050A3 - Virus detection method, primers therefor and screening kit - Google Patents

Virus detection method, primers therefor and screening kit Download PDF

Info

Publication number
WO2002103050A3
WO2002103050A3 PCT/GB2002/002847 GB0202847W WO02103050A3 WO 2002103050 A3 WO2002103050 A3 WO 2002103050A3 GB 0202847 W GB0202847 W GB 0202847W WO 02103050 A3 WO02103050 A3 WO 02103050A3
Authority
WO
WIPO (PCT)
Prior art keywords
virus
extension product
primer extension
nucleic acid
self
Prior art date
Application number
PCT/GB2002/002847
Other languages
French (fr)
Other versions
WO2002103050A2 (en
Inventor
Keith William Hart
Original Assignee
Univ Wales Medicine
Keith William Hart
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0114430A external-priority patent/GB0114430D0/en
Priority claimed from GB0207276A external-priority patent/GB0207276D0/en
Application filed by Univ Wales Medicine, Keith William Hart filed Critical Univ Wales Medicine
Priority to US10/480,852 priority Critical patent/US20060057561A1/en
Priority to CA002450164A priority patent/CA2450164A1/en
Priority to JP2003505371A priority patent/JP2004533256A/en
Priority to EP02738381A priority patent/EP1409730A2/en
Publication of WO2002103050A2 publication Critical patent/WO2002103050A2/en
Publication of WO2002103050A3 publication Critical patent/WO2002103050A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Discloses a novel detection and typing method for viruses, such as human papillomaviruses, based on real-time PCR using self-probing amplicon fluorescent primers. The method comprises: (IA) contacting the sample with a self-probing amplicon ('virus self-probing amplicon') comprising (i) a virus primer capable of hybridising to at least one target viral nucleic acid sequence and undergoing amplification thereof under primer amplification conditions to form a virus primer extension product; (ii) a virus probe comprising a nucleic acid sequence complementary to a target sequence of the virus primer extension product and capable of hybridisation thereto, provided that the self-probing amplicon is adapted to ensure that the virus probe is unresponsive to amplification under the primer amplification conditions; and (iii) a member of a virus signalling system, which system is capable of causing a detectable signal to be effected on hybridisation of the virus probe sequence to the virus primer extension product, whereby presence or absence of the target viral nucleic acid sequence in the sample is indicated by the detectable signal; (IB) amplifying the product of step (IA) under the primer amplification conditions to an extent enabling the detectable signal to be effected after step (II); and (II) separating the virus primer extension product from the target viral nucleic acid sequence; allowing the virus probe to hybridise to the target sequence of the virus primer extension product; and monitoring the signalling system. This method is quick, simple, specific, sensitive, and capable of estimating viral load per cell. The results of over 100 HPV typing reactions performed on cell lines, biopsies and cervical cytobrush samples are given which, when compared to the current reference HPV detection and typing technique, present a kappa value of 0.89. The method is also applicable to other viruses, such as SV40.
PCT/GB2002/002847 2001-06-14 2002-06-13 Virus detection method, primers therefor and screening kit WO2002103050A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US10/480,852 US20060057561A1 (en) 2001-06-14 2002-06-13 Virus detection method, primers therefor and screening kit
CA002450164A CA2450164A1 (en) 2001-06-14 2002-06-13 Virus detection method, primers therefor and screening kit
JP2003505371A JP2004533256A (en) 2001-06-14 2002-06-13 Virus detection method, virus detection primer, and screening kit
EP02738381A EP1409730A2 (en) 2001-06-14 2002-06-13 Virus detection method, primers therefor and screening kit

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0114430A GB0114430D0 (en) 2001-06-14 2001-06-14 Detection method
GB0114430.2 2001-06-14
GB0207276A GB0207276D0 (en) 2002-03-28 2002-03-28 Detection method
GB0207276.7 2002-03-28

Publications (2)

Publication Number Publication Date
WO2002103050A2 WO2002103050A2 (en) 2002-12-27
WO2002103050A3 true WO2002103050A3 (en) 2004-02-26

Family

ID=26246185

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2002/002847 WO2002103050A2 (en) 2001-06-14 2002-06-13 Virus detection method, primers therefor and screening kit

Country Status (5)

Country Link
US (1) US20060057561A1 (en)
EP (1) EP1409730A2 (en)
JP (1) JP2004533256A (en)
CA (1) CA2450164A1 (en)
WO (1) WO2002103050A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111733298A (en) * 2020-08-25 2020-10-02 圣湘生物科技股份有限公司 Composition, kit and method for detecting and typing polyoma virus and application thereof

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7838225B2 (en) * 1999-10-29 2010-11-23 Hologic, Inc. Methods for detection of a target nucleic acid by forming a cleavage structure using a reverse transcriptase
DE10338308B4 (en) * 2003-08-15 2006-10-19 Epigenomics Ag Method for the detection of cytosine methylations in DNA
US20090233272A1 (en) * 2003-12-23 2009-09-17 Autogenomics, Inc. Multiplexed Nucleic Acid Analysis with High Specificity
WO2005100610A2 (en) * 2004-04-15 2005-10-27 University College Cardiff Consultants Limited Virus detection method, primers therefor and screening kit
DE602005022759D1 (en) 2004-12-08 2010-09-16 Gen Probe Inc NUCLEIC ACIDIC ACID DETECTION FROM VARIOUS TYPES OF THE HUMAN PAPILLOMA VIRUS
JP2009533030A (en) * 2006-04-11 2009-09-17 ビオ−ラド・パストゥール HPV detection and quantification by real-time multiplex amplification
DE102006041970A1 (en) * 2006-08-28 2008-03-06 Genome Identification Diagnostics Gmbh Method and means for detecting human papillomavirus
GB0702557D0 (en) 2007-02-09 2007-03-21 Health Prot Agency Detection of human papillomavirus
EP1997914A1 (en) * 2007-06-01 2008-12-03 Università Degli Studi Di Milano - Bicocca Identification and quantification of oncogenic HPV nucleic acids by means of real-time PCR assays
WO2011084619A2 (en) * 2009-12-16 2011-07-14 Mark Stahl Elimination of pathogenic infection in farmed animal populations
US9845492B2 (en) * 2009-12-21 2017-12-19 Seegene, Inc. TSG primer target detection
EP2729581B1 (en) 2011-07-06 2018-10-03 Quest Diagnostics Investments Incorporated Direct amplification and detection of viral and bacterial pathogens
US10100349B2 (en) 2013-09-30 2018-10-16 President And Fellows Of Harvard College Methods of determining polymorphisms
US10280455B2 (en) 2015-12-30 2019-05-07 Bio-Rad Laboratories, Inc. Split-cycle and tape amplification
CN110904278B (en) * 2019-12-30 2023-01-17 申友基因组研究院(南京)有限公司 13 type high-risk HPV multiple fluorescence detection kit

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993002215A1 (en) * 1991-07-24 1993-02-04 Royal Free Hospital School Of Medicine Quantitative nucleic acid amplification
WO1993023566A1 (en) * 1992-05-21 1993-11-25 Isis Innovation Limited Nucleic acid detection and quantification
WO1995022626A1 (en) * 1994-02-21 1995-08-24 Stichting Researchfonds Pathologie Human papilloma virus detection in a nucleic acid amplification process using general primers
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639871A (en) * 1988-09-09 1997-06-17 Roche Molecular Systems, Inc. Detection of human papillomavirus by the polymerase chain reaction
WO1993002215A1 (en) * 1991-07-24 1993-02-04 Royal Free Hospital School Of Medicine Quantitative nucleic acid amplification
WO1993023566A1 (en) * 1992-05-21 1993-11-25 Isis Innovation Limited Nucleic acid detection and quantification
WO1995022626A1 (en) * 1994-02-21 1995-08-24 Stichting Researchfonds Pathologie Human papilloma virus detection in a nucleic acid amplification process using general primers

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
HART KEITH W ET AL: "Novel method for detection, typing, and quantification of human papillomaviruses in clinical samples.", JOURNAL OF CLINICAL MICROBIOLOGY, vol. 39, no. 9, September 2001 (2001-09-01), pages 3204 - 3212, XP002250694, ISSN: 0095-1137 *
JORDENS J ZOE ET AL: "Amplification with molecular beacon primers and reverse line blotting for the detection and typing of human papillomaviruses.", JOURNAL OF VIROLOGICAL METHODS, vol. 89, no. 1-2, September 2000 (2000-09-01), pages 29 - 37, XP002250695, ISSN: 0166-0934 *
PARK JONG SUP ET AL: "Physical status and expression of HPV genes in cervical cancers.", GYNECOLOGIC ONCOLOGY, vol. 65, no. 1, 1997, pages 121 - 129, XP002250696, ISSN: 0090-8258 *
THELWELL N ET AL: "Mode of action and application of Scorpion primers to mutation detection", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 28, no. 19, 1 October 2000 (2000-10-01), pages 3752 - 3761, XP002247004, ISSN: 0305-1048 *
WHITCOMBE D ET AL: "Detection of PCR products using self-probing amplicons and fluorescence", NATURE BIOTECHNOLOGY, NATURE PUBLISHING, US, vol. 17, no. 8, August 1999 (1999-08-01), pages 804 - 807, XP002226672, ISSN: 1087-0156 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111733298A (en) * 2020-08-25 2020-10-02 圣湘生物科技股份有限公司 Composition, kit and method for detecting and typing polyoma virus and application thereof
CN111733298B (en) * 2020-08-25 2020-11-20 圣湘生物科技股份有限公司 Composition, kit and method for detecting and typing polyoma virus and application thereof

Also Published As

Publication number Publication date
US20060057561A1 (en) 2006-03-16
CA2450164A1 (en) 2002-12-27
JP2004533256A (en) 2004-11-04
WO2002103050A2 (en) 2002-12-27
EP1409730A2 (en) 2004-04-21

Similar Documents

Publication Publication Date Title
WO2002103050A3 (en) Virus detection method, primers therefor and screening kit
Moberg et al. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer
EP3792364A1 (en) Method for detecting nucleic acid based on prokaryotic argonaute protein and application thereof
CA2074069A1 (en) Primers and process for detecting human papillomavirus genotypes by pcr
CA2321185A1 (en) Method for detection of target nucleic acids using pcr
WO1999014377A3 (en) Detection and identification of human papillomavirus by pcr and type-specific reverse hybridization
CA2378408A1 (en) Polynucleotide amplification method
EP1061135A3 (en) Methods and oligonucleotides for detecting nucleic acid sequence variations
AU6704596A (en) Method for detecting nucleic acids using nucleotide probes permitting both specific capture and detection
WO2006077102A3 (en) Method for the detection of hpv and probes, primers and kits
CA2268753A1 (en) Nucleic acid primers and probes for detecting oncogenic human papillomaviruses
WO2008018859A3 (en) Diagnostic kit for determining genotypes of a human papilloma virus and method of using thereof
CA2539703A1 (en) Detection of human papilloma virus (hpv) utilizing invasive cleavage structure assays
WO2023015259A3 (en) Methods and compositions for improved snp discrimination
AU650055B2 (en) Nucleotide sequences useful as type-specific probes, PCR primers and LCR probes for the amplification and detection of human papilloma virus, and related kits and methods
WO2003093797A3 (en) Polynucleotides for the detection and quantification of hepatitis b virus nucleic acids
EP0489442A1 (en) Synthetic oligonucleotides useful for the diagnosis of infections from different types of virus of the papilloma group and usage thereof
AU2002304643A1 (en) Detecting microorganisms of the yersinia pestis/yersinia pseudotuberculosis species
WO1999054496A3 (en) Method for typing of hla alleles
WO1995033854B1 (en) Use of a specific marker for detection of salmonella with pcr
Schmitt Performance characteristics of quantification assays for human immunodeficiency virus type 1 RNA
WO2001068913A3 (en) Nucleic acid detection method and system
Hibbitts et al. Human papilloma virus genotyping by surface-enhanced Raman scattering
AU3775099A (en) Methods, kits and compositions for detecting and quantitating target sequences
AU4064901A (en) Detection of human papilloma viruses

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002311464

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2450164

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002738381

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2003505371

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2002738381

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

ENP Entry into the national phase

Ref document number: 2006057561

Country of ref document: US

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 10480852

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 10480852

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2002738381

Country of ref document: EP